INTRODUCTION
============

Open carpal tunnel release (CTR) and trigger finger release (TFR) are common operations in hand surgery. In the United States, more than 500,000 CTRs are performed annually^[@R1]^; data on rates of TFR are limited, although estimates suggest up to 31,000 annual cases in the Medicare population alone.^[@R2]^ Although the technical steps of each operation are fairly routine, there is no standard of care concerning suture selection for closure of the palmar skin incision.

At our institution, surgeons performed these procedures similarly but had different skin closure preferences. Three different sutures were used for skin closure: poliglecaprone 25 (Monocryl), nylon (Ethilon), or chromic gut (all Ethicon, Inc.; Somerville, N.J.). Nylon is nonabsorbable. Absorbable Monocryl sutures were buried beneath the skin. Absorbable chromic was left external. Theoretical advantages of nonabsorbable suture include less reactivity resulting in a more aesthetic scar and greater strength; disadvantages include a propensity to unravel due to high memory and to cut through tissue ("cheese-wire") under tension.^[@R3],[@R4]^ Absorbable sutures have the benefit of not requiring suture removal.^[@R3]^

The purpose of this Palo Alto Veterans Affairs (PAVA) quality improvement study was to determine the optimal suture type for skin closure following CTR and TFR at our institution. We hypothesized that nylon sutures would have the lowest rate of dehiscence.

METHODS
=======

This retrospective chart analysis assessed consecutive patients in the PAVA Health Care System (Palo Alto, Calif.) who underwent CTR and/or TFR from August 2016 to August 2018. Surgeons, residents, and fellows were randomly assigned to cases based on a preset operative schedule. Sutures choice was attending sensitive; however, the majority of sutures were placed by residents and fellows who were equally versed in all techniques. Operations were performed through palmar incisions. Wounds were closed with one of the following techniques: interrupted deep dermal 4-0 Monocryl with Dermabond (Ethicon, Inc.; Somerville, NJ) skin adhesive or mattress sutures with 4-0 nylon or 4-0 chromic. Patients who underwent concurrent additional upper extremity procedures were excluded. The standard postprocedure protocol was a soft dressing for 4 days and patients were instructed to avoid heavy lifting for 2 weeks. A bulkier dressing or splint was applied if the patient required hands for transfers or ambulation. Patients followed up at 2 weeks, at which time the wound was checked and any nylon sutures were removed.

Demographics of patients were recorded. Using chart review, 30-day outcomes including wound complications (dehiscence and/or infection) and extra encounters (emergency department, clinic, and/or telephone) for pain, swelling, or other wound concerns were identified. "Dehiscence" was taken from the progress note texts and represented any wound separation noted by the provider. "Infection" included any episode of concern for infection from suture abscess to cellulitis. All outcomes were compared with suture type using chi-squared analysis and multivariable logistic regression. All analyses were performed using Stata/SE Version 15.0 (StataCorp LLC, College Station, Tex.).

RESULTS
=======

A total of 312 cases met inclusion criteria, with 133 CTR (42.6%) and 179 TFR (57.4%) operations (Table [1](#T1){ref-type="table"}). Average age was 65.7 ± 0.8 years, and patients were predominantly male (93.6%) with 29.1% prevalence of diabetes. There was no significant difference in demographic or clinical characteristics among suture type cohorts.

###### 

Demographic and Clinical Characteristics by Suture Cohort
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Based on a comparison of 30-day outcomes by suture type (Table [2](#T2){ref-type="table"}), incisions closed with Monocryl were significantly less likely to develop dehiscence (Monocryl 2.1%, nylon 10.5%, chromic 10.3%; *P* = 0.006) or infection (Monocryl 1.6%, nylon 7.4%, chromic 13.8%; *P* = 0.003), and less likely to prompt antibiotic use in the postoperative period (Monocryl 1.1%, nylon 5.3%, chromic 10.3%; *P* = 0.012). There was no significant difference in the number of cases that required additional procedures (*P* = 0.515). Incisions closed with Monocryl were also associated with fewer additional encounters, including emergency department, clinic, and phone calls (Monocryl 8.0%, nylon 16.8%, chromic 24.1%; *P* = 0.012).

###### 

Thirty-day Outcomes by Suture Type
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Suture type and diabetes were the only independent predictors of 30-day wound complications and extra wound-related encounters (Table [3](#T3){ref-type="table"}). Compared to closures with Monocryl, closures with nylon and chromic were significantly more likely to dehisce and/or become infected \[nylon: odds ratio (OR), 5.0; 95% CI, 1.9--13.3 and chromic: OR, 9.3; 95% CI, 2.7--32.4; *P* = 0.002\], and to be associated with an additional encounter (nylon: OR, 2.4; 95% CI, 1.1--5.3 and chromic: OR, 4.5; 95% CI, 1.6--12.9; *P* = 0.007).

###### 

Multivariable Analysis of 30-day Outcomes Compared with Monocryl
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DISCUSSION
==========

Suture selection for skin closure is often based upon surgeon preference, with little evidence to support the choice of suture material.^[@R5]^ Classic teaching prescribes the use of nonabsorbable suture for wound closure, largely due to greater tensile strength and an assumed superior ability to withstand motion of the hand in the postoperative period. However, this belief is not substantiated in the literature; a recent Cochrane meta-analysis of 5 randomized controlled trials comparing absorbable versus nonabsorbable suture following CTR failed to detect any clear difference in outcome measures of pain, wound inflammation, hand function, or scar satisfaction.^[@R3]^

Based on our nonrandomized series, closure with 4-0 buried Monocryl with Dermabond was in the best interest of our patients and providers, compared to closure with 4-0 external nylon or chromic. At PAVA, closure with Monocryl was less likely to dehisce, become infected, or prompt additional clinical encounters for wound-related concerns. An additional benefit is that the use of Monocryl does not require postoperative suture removal, saving patients time and discomfort, and reducing providers' clinical workload and resource utilization.^[@R3]^ In terms of cost, there is a relatively trivial cost difference amongst the three suture types, but the addition of Dermabond increases the price per closure for the Monocryl cohort. (Cost estimates are based on publicly-available prices on commercial websites. Relative pricing per packet, from most to least expensive, is as follows: chromic, Monocryl, and nylon. Use of Dermabond approximately triples the price of a Monocryl closure alone.) However, compared with the cost of additional visits, this still represents significant savings.

Future prospective randomized studies to generalize these findings and quantify the costs are needed. Comparative evaluation of long-term scarring with different suture types should also be considered. Suture allocation was not a major source of bias in our study due to the unsystematic participation of residents and fellows who close the incisions. Last, it is unknown whether Monocryl closure without Dermabond would yield comparable results, which could be considered for future investigation.

In conclusion, along the spectrum of innovative ideas, choosing Monocryl for the closure of open CTR and TFR incisions at PAVA represented a simple change that achieves the "Triple Aim" of improving the patient experience, improving health, and reducing healthcare costs.^[@R6]^ A lesson to all of healthcare, this quality improvement innovation was not borne out of complexity, but rather from critical evaluation and a desire to achieve more with less.
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